EU pharma strategy has patients and collaboration at its heart

Retrieved on: 2020-11-25 16:22:01

Tags for this article:

Intellectual property law

Patent law of the European Union

Supplementary protection certificate

Orphan drug

Intellectual property

Life Sciences

Health

Click the tags to see associated articles and topics

EU pharma strategy has patients and collaboration at its heart. View article details on hiswai:

Excerpt

These challenges and opportunities are not new, nor is the need to look at how we best incentivise innovation, but as the strategy acknowledges the ...

Article found on: www.pinsentmasons.com

View Original Article